a krescent program post-doctoral fellowship is an “in-training” award intended for applicants with a phd, md or equivalent degree. the objective is to attract and foster young investigators to initiate and/or continue training in kidney research.

the krescent program new investigator award is awarded to individuals who have clearly demonstrated excellence during their pre-doctoral and post-doctoral training in kidney disease. the award provides salary support for up to three years of the faculty appointment at the rank of assistant professor or its equivalent at a canadian university.

the purpose of this award is to assist such an individual to become established as a fully independent investigator in the field of kidney disease.

preference may be given to candidates who have been awarded and successfully completed a krescent program post-doctoral fellowship or allied health doctoral scholarship.

the career guidance for trainees (cgt) program provides grants of $30,000 - $50,000 over a one-year period to support demonstration projects that will model affordable approaches to improving trainees’ readiness for stable, fulfilling careers, whether by clarifying and improving their basic “ph.d.-level” skills, by helping them identify how they can best use their skills and interests to serve the needs of potential employers, by providing them approaches to thinking through their career options, or by other strategies.

applied research, innovation and entrepreneurship services (aries) of centennial college and college of massage therapist of ontario (cmto) are very pleased to announce the 2017 massage therapy research fund (mtrf) competition. the mtrf funding competition is now open to support high quality and rigorous research in massage therapy. we invite researchers to submit research project proposals till the application deadline on december 18, 2017 (11:59 p.m. et). grant recipients will be announced in february, 2018.

in this cycle of funding competition:

• up to $60,000 grant amount is available to fund projects.
• the maximum grant amount for a project is $40,000.
• the number of grants will depend on the number of quality submissions received.

eligible research topics include, but are not limited to:

• massage therapy effectiveness, efficacy and safety
• access to and delivery of massage therapy services
• professionalization of massage therapy
• massage therapy competencies and competency assessment
• evaluation of massage therapy practice

you can find more information at www.mtrf.ca. please promote and disseminate. for questions, please contact dr. pouria tavakkoli avval, program manager, massage therapy research fund at ptavakkoliavval@centennialcollege.ca.

applied research, innovation and entrepreneurship services (aries) of centennial college and college of massage therapist of ontario (cmto) are very pleased to announce the 2017 massage therapy research fund (mtrf) competition. the mtrf funding competition is now open to support high quality and rigorous research in massage therapy. we invite researchers to submit research project proposals till the application deadline on december 18, 2017 (11:59 p.m. et). grant recipients will be announced in february, 2018.

in this cycle of funding competition:

• up to $60,000 grant amount is available to fund projects.
• the maximum grant amount for a project is $40,000.
• the number of grants will depend on the number of quality submissions received.

eligible research topics include, but are not limited to:

• massage therapy effectiveness, efficacy and safety
• access to and delivery of massage therapy services
• professionalization of massage therapy
• massage therapy competencies and competency assessment
• evaluation of massage therapy practice

you can find more information at www.mtrf.ca. please promote and disseminate. for questions, please contact dr. pouria tavakkoli avval, program manager, massage therapy research fund at ptavakkoliavval@centennialcollege.ca.

the fy17 defense appropriations act provides $5 million (m) to the department of defense lupus research program (lrp) to support innovative and impactful research that addresses fundamental issues in lupus.  as directed by the office of the assistant secretary of defense for health affairs, the defense health agency (dha) j9, research and development directorate manages the defense health program (dhp) research, development, test, and evaluation (rdt&e) appropriation. the managing agent for the anticipated program announcements/funding opportunities is the congressionally directed medical research programs (cdmrp).

fy17 lrp program announcements and general application instructions for the following award mechanisms are posted on the grants.gov website. 

applications submitted to the fy17 lrp must address at least one of the three focus areas listed below:

•           understand lupus disease heterogeneity including, but not limited to, progressive stages of lupus disease over time, strategies and technologies to subtype patients, lupus disease mechanisms, biopsychosocial studies, personalized medicine, variation in treatment and its effects on patient outcomes, socioeconomic studies, environmental studies, and epidemiological studies.

•           understand how the underlying genetic components of lupus disease relate to clinical disease characteristics using functional genomic studies.

•           determine the pathobiology of lupus in target human tissues including, but not limited to, imaging studies, genetics of lupus disease in particular tissues, and metabolomics.

http://cdmrp.army.mil/funding/lrp

concept award – letter of intent due december 21, 2017, full application due january 4, 2018

• investigators at all academic levels
• supports high-risk studies that have the potential to reveal new avenues for investigation into lupus.
• must describe how the new idea will enhance existing knowledge of lupus.

·         must address at least one of the fy17 lrp focus areas

·         submission of letter of intent is required prior to full application submission

·         inclusion of preliminary data is encouraged

·         clinical trials are not allowed

·         maximum funding of $150,000 for total costs

• maximum period of performance is 1 year

impact award – letter of intent due december 21, 2017, full application due january 4, 2018

• assistant professor level or above (or equivalent)
• supports new high-risk, high-reward ideas that could lead to critical discoveries or major advancements in the field of lupus research.
• must describe how the new idea will enhance existing knowledge of lupus or develop a novel course of investigation.
• emphasis is on impact

·         must address at least one of the fy17 lrp focus areas

·         submission of letter of intent is required prior to full application submission

·         inclusion of preliminary data is encouraged

·         clinical trials are not allowed

·         maximum funding of $525,000 for total costs

• maximum period of performance is 3 years

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline. all applications must conform to the final program announcements and general application instructions that will be available for electronic downloading from the grants.gov website.  the application package containing the required forms for each award mechanism will also be found on grants.gov.  a listing of all cdmrp funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420. 

applications must be submitted through the federal government’s single-entry portal, grants.gov.  submission deadlines are not available until the program announcements are released.  for email notification when program announcements are released, subscribe to program-specific news and updates under “email subscriptions” on the ebrap homepage at https://ebrap.org.  for more information about the lrp or other cdmrp-administered programs, please visit the cdmrp website (http://cdmrp.army.mil).

point of contact:

cdmrp help desk

301-682-5507
help@ebrap.org

futher details about the global call, including loi instructions, selection criteria, and more are available online. 

visit www.cifar.ca/cifar-global-call-for-ideas

the canadian institute for advanced research (cifar) invites the global research community to submit proposals for new programs that address complex, fundamental questions of importance to the world. ideas must be novel, bold and potentially transformative to warrant the creation of a long-term, interdisciplinary and collaborative research program. proposals will be accepted from all areas of research.

• call for letters of intent opens: november 15, 2017 
• loi deadline: january 21, 2018 
• announcement of short-listed proposals: spring 2018 
• final proposal deadline: fall 2018 
• announcement of competition results: spring 2019

the ict rewarding success is expected to:

1. incentivize multidisciplinary research teams and their healthcare and innovation partners to design, adopt, and evaluate interventions implemented into a healthcare delivery organization that enhance value-based care, health system sustainability, and health outcomes.
2. support innovative process transformations that improve health outcomes and value for canada’s healthcare investment.

in canada, the dramatic and increasing number of overdoses and deaths related to the use of opioids is a national public health crisis. the government of canada is committed to tackling this crisis and has emphasized the need for a strong evidence base through the canadian drugs and substances strategy (cdss), and the joint statement of action to address the opioid crisis. this funding opportunity will support expedited knowledge synthesis grants to rapidly inform policies on opioids related to one or more pillars of cdss (i.e. prevention, treatment, harm reduction and enforcement).

knowledge syntheses are the cornerstone of knowledge translation. they interpret vast libraries of scientific literature into knowledge that is reliable, relevant and readable for knowledge users. syntheses are comprehensive and apply scientific methods to literature analysis which minimizes the risk of bias and error that may accompany single studies, so health policy and practice decisions are less likely to be based on insufficient or premature evidence. syntheses are also a means to integrate established literature with other forms of knowledge, to map the state of current knowledge on a topic, revealing to knowledge users where there is or is not strong evidence to inform their decisions, or to guide researchers to new areas of research.

this funding opportunity is expected to:

• address the pressing evidence needs of knowledge users within one or more pillars of the cdss.
• increase the application of knowledge related to one or more pillars of the cdss in policy and decision-making, in order to address the most urgent elements of the opioid crisis, including opioid-related mortality rates.
• encourage syntheses that consider sub-populations and/or the biological and social determinants of problematic opioid use.